Tetra Stock

tetradiscovery.comHealthcare / BioTech & PharmaFounded: 2010Funding to Date: $40.04MM

Tetra Therapeutics is clinical stage biotechnology company developing medicines for Alzheimer's Disease, Fragile X syndrome, Traumatic Brain Injury, major depression and schizophrenia.

Register for Details

For more details on financing and valuation for Tetra, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

OverviewFinancingsValuation

Enterprise Value (based on primary financings)

Powered by Forge Data
Enterprise Value

View Enterprise Value for Tetra.

Register Today

Team

Management Team

Joseph Collard
Board Member & Chief Business Officer
Harvey Elgersma
Chief Financial Officer
Richard Nugent Ph.D
Director of Chemistry
Mark Gurney Ph.D
Founder, Chief Executive Officer & Chairman
Scott Reines Ph.D
Chief Medical Officer

Board Members

Donald Parfet
Biosciences Research and Commercialization Center
Lance Stewart Ph.D
Paul D'Amato
Grand Angels
Douglas Morton Ph.D
Mark Gurney Ph.D
Rob Jandernoa
Akira Kato Ph.D
Joseph Collard

Other companies like Tetra in the BioTech & Pharma sector

Sector
Last Round Est. Valuation
$3.67B
Sector
Last Round Est. Valuation
$8.45B
Sector
Last Round Est. Valuation
$500MM
Sector
Last Round Est. Valuation
$8.84B
Sector
Last Round Est. Valuation
$1.01B
Sector
Last Round Est. Valuation
$303.94MM
Sector
Last Round Est. Valuation
$4.74B

News Highlights

Startups To Watch: Stix, Sanzo, WorkPatterns, Jamm, Ceresa, BRIO Systems, Proper, Tetra Insights
These eight startups are worth highlighting for their interesting approaches despite their smaller raises.
Tetra Discovery Partners Announces Name Change to Tetra Therapeutics
Updated on: Oct 2, 2023

PLEASE READ THESE IMPORTANT LEGAL NOTICES & DISCLOSURES

Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.